RC

Robert Clarke, PhD

Director

Alphageneron Pharmaceuticals

Therapeutic Areas

Alphageneron Pharmaceuticals Pipeline

DrugIndicationPhase
ENKASTIM™mHsp70+ CancersClinical
AP-161™mHsp70+ CancersClinical
AP-205™mHsp70+ CancersClinical
AP-401™Solid Tumors (CD155/CD73+)Pre-clinical